Cargando…

The effect of enhancing quality of life in patients intervention for advanced lung cancer: Protocol for a randomized clinical study

OBJECTIVE: The objective of this present research is to evaluate the effect of the intervention of enhancing quality of life in patients in patients with advanced lung cancer. METHODS: Our research is carried out as a randomized clinical trial which will be implemented from December 2020 to October...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xianhong, Qin, Ke, Yuan, Chunyan, Song, Shiqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748172/ https://www.ncbi.nlm.nih.gov/pubmed/33371108 http://dx.doi.org/10.1097/MD.0000000000023682

Ejemplares similares

Safety and efficacy of apatinib combined with iodine-125 in chemotherapy-refractory advanced lung cancer: A case report
por: Zhang, Yunchao, et al.
Publicado: (2020)

Willingness to pay for a quality-adjusted life year among advanced non-small cell lung cancer patients in Viet Nam, 2018
por: Ha, Thuy Van, et al.
Publicado: (2020)

The Efficacy of Combining EGFR Monoclonal Antibody With Chemotherapy for Patients With Advanced Nonsmall Cell Lung Cancer: A Meta-Analysis From 9 Randomized Controlled Trials
por: Sheng, Jin, et al.
Publicado: (2015)

The effects of traditional Chinese medicine combined with chemotherapy on immune function and quality of life in patients with non-small cell lung cancer: A protocol for systematic review and meta-analysis
por: Zhao, Li-Na, et al.
Publicado: (2020)

Frequency of fibromyalgia in a cohort of Turkish patients with lung cancer and its effect on pain, sleep quality, fatigue and quality of life
por: Öztürk, Akin, et al.
Publicado: (2023)

Efficacy and safety of icotinib in the treatment of advanced EGFR mutation-positive nonsmall cell lung cancer: A meta-analysis of randomized controlled trials
por: Li, Dailong, et al.
Publicado: (2022)

Efficacy and safety of anti-PD-1 and anti-PD-1 combined with anti-CTLA-4 immunotherapy to advanced melanoma: A systematic review and meta-analysis of randomized controlled trials
por: Hao, Chunyan, et al.
Publicado: (2017)

Effects of tyrosine kinase inhibitor therapy on skin toxicity and skin-related quality of life in patients with lung cancer: An observational study
por: Tseng, Li-Chuan, et al.
Publicado: (2020)

Anti-PD-1/PD-L1 antibody therapy for pretreated advanced nonsmall-cell lung cancer: A meta-analysis of randomized clinical trials
por: Zhou, Guo-Wu, et al.
Publicado: (2016)

S-1-based concurrent chemoradiotherapy in the treatment of locally advanced non-small cell lung cancer: A systematic review and meta-analysis protocol
por: Liu, Feiyu, et al.
Publicado: (2018)

CYFRA 21-1 is an early predictor of chemotherapeutic effectiveness in advanced nonsmall cell lung cancer: An observational study
por: Zhao, Tongwei, et al.
Publicado: (2016)

Lifestyle interventions after colorectal cancer surgery using a mobile digital device: A study protocol for a randomized controlled trial
por: Kim, Young Il, et al.
Publicado: (2022)

Life quality improvement of patients with non-small cell lung cancer undergoing targeted therapy: A case study of continuous care
por: Min, Yonghua, et al.
Publicado: (2023)

Prognostic significance of PD-L1 in advanced non-small cell lung carcinoma
por: Zhao, Yanjie, et al.
Publicado: (2020)

Effects of S-1 combined with radiotherapy in the treatment of advanced esophageal cancer: A systematic review and meta-analysis protocol
por: Wang, Wei, et al.
Publicado: (2018)

Concurrent vs sequential chemoradiotherapy for patients with advanced non–small-cell lung cancer: A meta-analysis of randomized controlled trials
por: Xiao, Wei, et al.
Publicado: (2021)

The efficacy and toxicity of induction chemotherapy plus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: A meta-analysis of randomized controlled trials
por: Wang, Peirong, et al.
Publicado: (2020)

Surgical Intervention Improves Survival for Metastatic Non-Small Cell Lung Cancer Patients
por: Shen, Hong, et al.
Publicado: (2016)

Durable response to osimertinib in an advanced lung adenocarcinoma patient with an uncommon EGFR T854A mutation: A case report
por: Zhao, Nan, et al.
Publicado: (2022)

A clinical study of traditional Chinese medicine prolonging the survival of advanced gastric cancer patients by regulating the immunosuppressive cell population: A study protocol for a multicenter, randomized controlled trail
por: Pan, Xiaoting, et al.
Publicado: (2020)

Comparative study of the genomic landscape and tumor microenvironment among large cell carcinoma of the lung, large cell neuroendocrine of the lung, and small cell lung cancer
por: Li, Fanghua, et al.
Publicado: (2023)

Clinical efficacy and safety of Huachansu injection combination with platinum-based chemotherapy for advanced non-small cell lung cancer: A systematic review and meta-analysis of randomized controlled trials
por: Tan, Xinmei, et al.
Publicado: (2021)

Combined low miRNA-29s is an independent risk factor in predicting prognosis of patients with hepatocellular carcinoma after hepatectomy: A Chinese population-based study
por: Zhang, Zhen, et al.
Publicado: (2017)

Weekly versus triweekly cisplatin-based concurrent chemoradiotherapy in the treatment of locally advanced cervical carcinoma: An updated meta-analysis based on randomized controlled trials
por: Zhu, Jiahao, et al.
Publicado: (2020)

Interventions for cancer-related pain: Protocol of an umbrella systematic review and network meta-analysis
por: Xu, Tao, et al.
Publicado: (2019)

Angiogenesis inhibitors for the treatment of small cell lung cancer (SCLC): A meta-analysis of 7 randomized controlled trials
por: Li, Qing, et al.
Publicado: (2017)

Determinants of Quality Care and Mortality for Patients With Locally Advanced Cervical Cancer in Virginia
por: Showalter, Timothy N., et al.
Publicado: (2016)

Bisphosphonates and risk of lung cancer: Protocol for a systematic review and meta-analysis
por: Li, Minghao, et al.
Publicado: (2021)

Efficacy of Addition of Antiangiogenic Agents to Taxanes-Containing Chemotherapy in Advanced Nonsmall-Cell Lung Cancer: A Meta-Analysis and Systemic Review
por: Sheng, Jin, et al.
Publicado: (2015)

Lung metastasis from thyroid cancer: A case report of unusual imaging presentation of lung metastases
por: Song, Wenjing, et al.
Publicado: (2023)

Change in expressional level and clinicopathological significance of miR-193b-3p in non-small cell lung cancer
por: Xiao, Feng, et al.
Publicado: (2023)

Efficacy and safety of Kanglaite plus EGFR-TKI in the treatment of advanced non-small cell lung cancer: A meta-analysis of 13 RCTs
por: Li, Dailong, et al.
Publicado: (2022)

Exploration of immune-related cells and ceRNA in squamous cell lung cancer
por: Wang, Lijun, et al.
Publicado: (2021)

Doublet Versus Single Agent as Second-Line Treatment for Advanced Gastric Cancer: A Meta-Analysis of 10 Randomized Controlled Trials
por: Zhang, Yong, et al.
Publicado: (2016)

Hyperthermic intraperitoneal chemotherapy combined with systemic chemotherapy for gastric cancer peritoneal carcinomatosis: A protocol for systematic review and meta-analysis of randomized controlled trials
por: Lu, Yidan, et al.
Publicado: (2020)

Apatinib combined with S-1 as second-line therapy in advanced gastric cancer
por: Qiu, Zhi-Yuan, et al.
Publicado: (2021)

Adjuvant chemotherapy for locally advanced rectal cancer in elderly patients after neoadjuvant chemoradiotherapy and surgery: Toxicity and survival outcomes
por: Sun, Quanquan, et al.
Publicado: (2020)

Clinical and individual factors of quality of life of chronic liver disease patients at University of Gondar comprehensive specialized hospital, Northwest Ethiopia 2022
por: Teshome, Eliud, et al.
Publicado: (2023)

Improving functional outcome and quality of life for patients with metastatic lesion of acetabulum undergoing cement augmentation
por: Yan, Taiqiang, et al.
Publicado: (2019)

Optimal tumor shrinkage predicts long-term outcome in advanced nonsmall cell lung cancer (NSCLC) treated with target therapy: Result from 3 clinical trials of advanced NSCLC by 1 institution
por: He, Xiaobo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0f43mecju084l1fap5vurknv43